Maxwell D. Janosky, MD

Maxwell D. Janosky, MD

Maxwell D. Janosky, MD

  • Hematology
  • Oncology

Languages Spoken

  • Russian
  • Spanish

Related Practices

  • Hematology/Oncology Physicians of Englewood

Specialties, Procedures &
Conditions Treated

Primary Areas of Practice

  • Hematology
  • Oncology

Other Areas of Practice

  • Bloodless Medicine
  • Cancer Prevention


  • Cancer Pain Management
  • Chemotherapy
  • Immunotherapy
  • Infusion Therapy

Conditions Treated

  • Amyloidosis
  • Anemia
  • Bone Marrow Failure
  • Brain Cancer
  • Cervical Cancer
  • Clotting Disorders
  • Factor Deficiency
  • Head and Neck Cancers
  • Laryngeal Cancer
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Macroglobulinemia
  • Melanoma
  • Myelodysplastic Syndrome
  • Myeloma
  • Neutropenia
  • Oral Cancer
  • Ovarian Cancer
  • Polycythemia
  • Polycythemia Vera
  • Sarcoma
  • Sickle Cell Disease
  • Skin Cancer
  • Thalassemia
  • Throat Cancer
  • Thrombocytopenia
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer
  • White Blood Cell Disorders

Locations &


  • Hematology Oncology Physicians of Englewood, PA

    350 Engle Street 5th Floor, Berrie Center Englewood, NJ 07631

    Main: 201-568-5250
    Fax: 201-568-5358


Insurances Accepted

Below is a list of the insurance plans that your provider participates in. It is very important that you contact your insurance company prior to receiving services or care. Each health insurance plan is different and some provide different levels of coverage: only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

1199 (SEIU)

  • 1199 (SEIU)


  • Aetna HMO
  • Aetna PPO
  • Aetna POS
  • Aetna Medicare Managed Care
  • Medsolutions
  • Meritan Health


  • Amerivantage
  • Amerigroup Medicaid


  • AmeriHealth HMO
  • AmeriHealth PPO
  • Value Network (Exchange Plan)
  • AmeriHealth Administrator


  • APWU Health Plan


  • Great-West Healthcare (GWH)
  • Cigna HMO
  • Cigna PPO
  • Cigna Supplemental
  • Health Partners

Clover Health

  • Clover Health

Consumer Health Network (CHN)



  • CoreSource


  • CCN


  • EmblemHealth EPO
  • EmblemHealth EPO2
  • EmblemHealth GHI PPO
  • EmblemHealth GHI CBP
  • EmblemHealth FEHB
  • EmblemHealth FEHBP
  • EmblemHealth National
  • EmblemHealth PPO1
  • EmblemHealth PPO2
  • EmblemHealth PPO3
  • EmblemHealth Tri-State
  • Vytra

Empire BCBS

  • Blue Access Network
  • Blue Priority
  • Direct HMO
  • Direct PPO
  • Empire BCBS EPO
  • Empire BCBS HMO
  • Pathway EPO
  • Pathway HMO
  • Empire BCBS POS
  • Empire BCBS PPO
  • Prism
  • Silver
  • Total Blue

Empire Plan (NYSHIP)

  • Empire Plan (NYSHIP)

First Health

  • First Health

Galaxy Health Network

  • Galaxy Health Network PPO


  • GEHA Health Plan

Horizon BCBS

  • Horizon BCBS EPO
  • Federal Employee Program
  • Horizon BCBS Medicare Managed Care
  • NJ Carpenters Fund
  • OMNIA Tier 1
  • Traditional
  • Horizon BCBS PPO
  • Horizon BCBS HMO

Horizon NJ Health

  • Horizon NJ Health Medicaid


  • Local 825
  • MagnaCare PPO

Mail Handlers

  • Mail Handlers Benefit Plan (MHBP)


  • Medicaid NJ


  • Medicare NJ


  • Beech Street
  • MultiPlan Humana
  • PHCS
  • Pomco
  • MultiPlan Worker’s Comp

MVP Health Care

  • MVP Health Care PPO


  • NALC Health Benefit Plan

Nippon Life Insurance Co of America

  • Nippon Life Benefits


  • Freedom
  • Liberty
  • Garden State Network
  • Oxford Medicare
  • Metro


  • Choice Care
  • QualCare EPO
  • QualCare FEHB
  • QualCare GHI PPO
  • QualCare HMO
  • QualCare Humana
  • Oscar
  • QualCare PPO
  • QualCare Worker's Comp

Railroad Medicare

  • Railroad Medicare NJ

TRICARE North Region

  • DVA


  • UMR


  • AARP
  • Commercial and Marketplace
  • Compass Benefit (Exchange)
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • Medica
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • River Valley
  • UnitedHealthcare StudentResources

United Healthcare Community and State

  • United Healthcare Community and State Medicare
  • United Healthcare Community and State Medicaid (NJ Family Care)
  • Dual Complete


  • Wellcare Medicaid Managed Care
  • Wellcare Medicare Managed Care


About Maxwell D. Janosky

Dr. Janosky is board certified in internal medicine, hematology, and oncology. A member of the Englewood Health Physician Network, he specializes in blood disorders, blood cancer, brain cancer, head and neck cancer, endocrine cancer, dermatological cancer, and gynecological cancer. He has also practiced as a leukemia and lymphoma hospitalist. Dr. Janosky has particular interest in biologic agents, cancer prevention, chemotherapy, hereditary cancer predisposition, immunologic approaches, and pain management and palliative care. After receiving his MD from Loma Linda University, he did an internal medicine residency at the University of California, San Francisco, and a hematology/oncology fellowship at New York University. He participates in clinical trials, as well as an ongoing basic science project on matrix metalloproteinase inhibition for the prevention of breast cancer metastasis.

Honors & Awards

  • 2019: Bergen Magazine Top Doctors
  • 2019: Castle Connolly Regional Top Doctors
  • 2014: Franco Muggia Clinical Trials Award, New York University

Professional Memberships

  • American Society of Hematology
  • American Society of Clinical Oncology

Committees and Leadership Positions

  • Medicine Professional Practice Committee, Department of Hematology and Oncology
  • VTE Committee
  • 2009-2010: Mentor, Residency Diversity Committee Mentorship Program, University of California, San Francisco

Global Health and Community Health Activities

  • 2017: A Community Conversation on Prostate Cancer Education

Education &

Education & Degrees

MD: Loma Linda University School of Medicine


UCSF Medical Center


New York University Medical Center, Hematology/Oncology

Board Certifications

  • Internal Medicine
  • Hematology
  • Medical Oncology

Other Certifications

  • Optune®-Certified



  • Winer A, Janosky M, Harrison B, Zhong J, Moussai D, Siyah P, Schatz-Siemers N, Zeng J, Adams S, Mignatti P. Inhibition of Breast Cancer Metastases by Presurgical Treatment with an Oral Matrix Mettaloproteinase Inhibitor: A Preclinical Proof-of-Principle Study. Molecular Cancer Therapeutics. July 27 2016. 15 (10): 2370-2377.
  • Janosky M, Bian J, Dhage S, Levine J, Silverman J, Jors K, Moy L, Cangiarella J, Muggia F, Adams S. Primary Large Cell Neuroendocrine Carcinoma of the Breast, a Case Report with an Unusual Clinical Course. Breast Journal. 2015 May. 21 (3): 303-307.
  • Janosky M, Sabado RL, Cruz C, Vengco I, Hasan F, Winer A, Moy L, Adams S. MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy. Journal for Immunotherapy of Cancer 2014, 2:32.
  • Janosky M, Bian J, Dhage S, Levine J, Silverman J, Jors K, Moy L, Cangiarella J, Muggia F, Adams S. Primary Large Cell Neuroendocrine Carcinoma of the Breast, a case report with an unusual clinical course. The Breast Journal, 21(2): 2015.
  • Janosky M, Sabado R, Cruz C, Vengco I, Hasan F, Adams S. Ex-vivo detectable Mage-specific T cells correlate with complete remission in metastatic breast cancer patients after sequential immuno-endocrine therapy. Journal of Immunotherapy, 2012. 35(9): p. 730.
  • Daud A, Janosky M, Dubey S. Adjuvant Therapy in Melanoma: New Combination Cytokine, and Other Strategies. Medscape Review. 2008.
  • Rugo H, Carey L, Janosky M. Emerging Therapeutic Options for Patients with ER/PR/HER2-Negative Metastatic Breast Cancer. “The Oncologist”